The Economist has a story following a PLoS Medicine paper from John Ioannidis and colleagues which argues that scientific publishing may be biased toward high-profile papers that may have less accurate findings. "With so many scientific papers chasing so few pages in the most prestigious journals, the winners could be the ones most likely to oversell themselves," the article says.